FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q2 EPS of ($0.25), in-line with the analyst estimate of ($0.25).
For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.
... More
